Hans-Peter Brecht
Hans-Peter Brecht, Chief Operating Officer of biomedical imaging firm PhotoSound Technologies, is working on the final development and commercialisation of a dual-modality ultrasound /photoacoustic imaging system called MoleculUS.
Brecht says the MoleculUS could replace X-ray mammography with a noninvasive and painless procedure and reduce the need for follow-up biopsies.
Register for FREE to keep reading
Join 15,000+ photonics professionals staying ahead with:
- Exclusive insights, funding alerts & market trends
- Curated newsletters and digital editions
- Access to The Photonics100 list of R&D champions
- Exclusive panels & roundtables for professional development
- Technical White Papers & product updates to guide smarter decisions
Sign up now
Already a member? Log in here
Your data is protected under our privacy policy.
